Okan Yildiz

Okan Yildiz

Auto-generated profile, based on publicly available information

Okan Yildiz

Department of Cardiovascular Surgery, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul 34303, Türkiye

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
HTHasan Tola
Hasan Tola
EOErkut Ozturk
Erkut Ozturk
OYOkan Yildiz
Okan Yildiz
EEErsin Erek
Ersin Erek
SHSertac Haydin
Sertac Haydin
IBIhsan Bakir
Ihsan Bakir

14 July 2021 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
OYOkan Yildiz
Okan Yildiz
BKBanu Kose
Banu Kose
ITI. Cansaran Tanidir
I. Cansaran Tanidir
KPKerem Pekkan
Kerem Pekkan
AGAlper Guzeltas
Alper Guzeltas
SHSertac Haydin
Sertac Haydin
PURPOSE This study was planned to assess the application of three-dimensional (3D) cardiac modeling in preoperative evaluation for complex congenital heart surgeries. METHODS From July 2015 to September 2019, 18 children diagnosed with complex congenital heart diseases (CHDs) were enrolled in this study (double outlet right ventricle in nine patients, complex types of transposition of the great arteries in six patients, congenitally corrected transposition of the great arteries in two patients, and univentricular heart in one patient). The patients' age ranged from 7 months to 19 years (median age, 14 months). Before the operation, 3D patient-specific cardiac models were created based on computed tomography (CT) data. Using each patient's data, a virtual computer model (3D mesh) and stereolithographic (SLA) file that would be printed as a 3D model were generated. These 3D cardiac models were used to gather additional data about cardiac anatomy for presurgical decision-making. RESULTS All 18 patients successfully underwent surgeries, and there were no mortalities. The 3D patient-specific cardiac models led to a change from the initial surgical plans in 6 of 18 cases (33%), and biventricular repair was considered feasible. Moreover, the models helped to modify the planned biventricular repair in five cases, for left ventricular outflow tract obstruction removal and ventricular septal defect enlargement. 3D cardiac models enable pediatric cardiologists to better understand the spatial relationships between the ventricular septal defect and great vessels, and they help surgeons identify risk structures more clearly for detailed planning of surgery. There was a strong correlation between the models of the patients and the anatomy encountered during the operation. CONCLUSION 3D cardiac models accurately reveal the patient's anatomy in detail and are therefore beneficial for planning surgery in patients with complex intracardiac anatomy.

3 October 2018 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
IOIsmihan Selen Onan
Ismihan Selen Onan
OYOkan Yildiz
Okan Yildiz
BTBehzat Tüzün
Behzat Tüzün
BTBarış Timur
Barış Timur
SHSertaç Haydin
Sertaç Haydin

7 August 2017 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
YOYildiz Okan
Yildiz Okan
HSHaydin Sertac
Haydin Sertac
EOErkut Ozturk
Erkut Ozturk
KTKasar Taner
Kasar Taner
OSOnan I. Selen
Onan I. Selen
GAGuzeltas Alper
Guzeltas Alper

30 April 2018 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
OYOkan Yıldız
Okan Yıldız
TKTaner Kasar
Taner Kasar
EÖErkut Öztürk
Erkut Öztürk
BTBehzat Tüzün
Behzat Tüzün
HAHüsnü Fırat Altın
Hüsnü Fırat Altın
SHSertaç Haydin
Sertaç Haydin
This study aims to evaluate the surgical results of our clinic according to presumption systems of Risk Adjustment in Congenital Heart Surgery, Aristotle Basic Complexity score, Aristotle Comprehensive Complexity score, and Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality categories and to compare the efficiency of these systems in predicting morbidity and mortality. In the study, classification and the risk scoring were performed with the four different systems for 1,950 patients (1,038 males, 912 females; mean age 5.5 months; range, 1 day to 18 years) who were administered congenital heart surgery between 1 October 2012 and 31 December 2016. The hospital mortality and morbidity were calculated for each category from the four models. The discriminatory ability of the models was determined by calculating the area under the receiver operating characteristic curve and the receiver operating characteristic curves of the four models were compared. Median weight of the patients was 7.2 kg (range, 1.8-80 kg). Among the patients, 53% were males and 47.5% were younger than one year of age. Of totally 1,950 operations, mortality was observed in 149 (7.6%) and morbidity was observed in 541 (27.7%). Areas under the receiver operating characteristic curve for mortality were 0.803, 0.795, 0.729, and 0.712 for the Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality categories, Aristotle Comprehensive Complexity, Risk Adjustment in Congenital Heart Surgery, and Aristotle Basic Complexity scores, respectively. Areas under the receiver operating characteristic curve for morbidity were 0.732, 0.731, 0.730, and 0.685 for the Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality categories, Risk Adjustment in Congenital Heart Surgery, Aristotle Comprehensive Complexity, and Aristotle Basic Complexity scores, respectively. Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality categories, Risk Adjustment in Congenital Heart Surgery, Aristotle Basic Complexity, and Aristotle Comprehensive Complexity score systems were effective in predicting the morbidities and mortalities of patients who underwent congenital heart surgery and evaluating the performance of the surgical centers. Society of Thoracic Surgeons and European Association for Cardiothoracic Surgery mortality categories were on the forefront due to high feasibility and performance. Aristotle Basic Complexity score system had the lowest performance. Combinations of systems will provide the most benefit during evaluation of results.

24 November 2015 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
IOIsmihan Selen Onan
Ismihan Selen Onan
EOErkut Ozturk
Erkut Ozturk
OYOkan Yildiz
Okan Yildiz
HAHusnu Firat Altin
Husnu Firat Altin
EOEnder Odemis
Ender Odemis
EEErsin Erek
Ersin Erek
OBJECTIVES To investigate the effects of intravenous iloprost on pulmonary artery hypertension (PAH) in infants undergoing congenital heart surgery. METHODS In this prospective, randomized study, the study group (n = 15) received a continuous infusion of iloprost (2.0 ng/kg/min) that was delivered immediately after weaning from cardiopulmonary bypass and continued for 72 h postoperatively. Patients in the control group (n = 12) were managed conventionally. The groups were compared in terms of postoperative data, including systolic and mean pulmonary artery (PA) pressures, PA/systemic pressure ratio, lactate level, PAH crisis, ventilation time, reintubation and lengths of intensive care unit (ICU) and hospital stay. Transthoracic echocardiography was used to assess PA pressures at 1 day, 7 days and 30 days after surgery. RESULTS No mortality occurred. PAH crisis occurred in 2 (16.6%) patients in the control group and 4 (26.7%) patients in the study group (P = 0.53). Postoperative PA pressures and PA/systemic pressure ratios were similar between the groups (P > 0.05). The durations of ICU (P = 0.40) and hospital (P = 0.98) stays were similar between the groups. Echocardiographic studies demonstrated a significant decrease in postoperative PA pressures in the control (P = 0.001) and study (P = 0.0001) groups. However, no significant change was observed between the groups (P > 0.05). The Tukey multiple comparison test showed a significant decrease in PA pressures at each follow-up in both groups (P < 0.05). CONCLUSIONS Intravenous iloprost demonstrated no additional benefit over the conventional management of infants with PAH after repair of intracardiac defects. Clinicians may prefer other alternative agents in infants with a high risk of PAH crisis.